Biomedical Engineering Reference
In-Depth Information
[188]
Ran D, WJ Shia, MC Lo, JB Fan, DA Knorr, PI Ferrell, Z Ye, M Yan, L Cheng, DS Kaufman,
et al
. (2013). RUNX1a enhances hematopoietic lineage commitment from human embryonic
stem cells and inducible pluripotent stem cells. Blood 121: 2882-2890.
[189]
Jaremko KL and Y Marikawa (2013). Regulation of developmental competence and commit-
ment towards the definitive endoderm lineage in human embryonic stem cells. Stem Cell
Research 10: 489-502.
[190]
Le KN, CW Hwang, AR Tzafriri, MA Lovich, A Hayward and ER Edelman (2009). Vascular
regeneration by local growth factor release is self-limited by microvascular clearance.
Circulation 119: 2928-2935.
[191]
Jeon O, SJ Song, HS Yang, S-H Bhang, K S.-W., MA Sung, JH Lee and B-S Kim (2008).
Long-term delivery enhances
in vivo
osteogenic efficacy of bone morphogenetic protein-2
compared to short-term delivery. Biochemical and Biophysical Research Communications
369: 774-780.
[192]
McKay B and HS Sandhu (2002). Use of recombinant human bone morphogenetic protein-2
in spinal fusion applications. Spine 27: S66-S85.
[193]
Steinert AF, U Noth and RS Tuan (2008). Concepts in gene therapy for cartilage repair. Injury
39(Suppl 1): S97-S113.
[194]
Geiben-Lynn R, K Frimpong-Boateng and NL Letvin (2011). Modulation of plasmid DNA
vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination. Clinical
and Vaccine Immunology 18: 533-538.
[195]
Lesina E, P Dames and C Rudolph (2010). The effect of CpG motifs on gene expression and
clearance kinetics of aerosol administered polyethylenimine (PEI)-plasmid DNA complexes in
the lung. Journal of Controlled Release 143: 243-250.
[196]
Geiben-Lynn R, JR Greenland, K Frimpong-Boateng, N van Rooijen, AH Hovav and NL
Letvin (2008). CD4+ T lymphocytes mediate
in vivo
clearance of plasmid DNA vaccine antigen
expression and potentiate CD8+ T-cell immune responses. Blood 112: 4585-4590.
[197]
Santos JL, D Pandita, J Rodrigues, AP Pego, PL Granja and H Tomas (2011). Non-viral gene
delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engi-
neering and regeneration. Current Gene Therapy 11: 46-57.
[198]
Ramos J, HC Huang and K Rege (2013). Delivery of plasmid DNA to mammalian cells using
polymer-gold nanorod assemblies. Methods in Molecular Biology 991: 81-91.
[199]
Thiersch M, M Rimann, V Panagiotopoulou, E Ozturk, T Biedermann, M Textor, TC
Luhmann and H Hall (2013). The angiogenic response to PLL-g-PEG-mediated HIF-1alpha
plasmid DNA delivery in healthy and diabetic rats. Biomaterials 34: 4173-82.
[200]
Kurosaki T, M Uematsu, K Shimoda, K Suzuma, M Nakai, T Nakamura, T Kitahara, T Kitaoka
and H Sasaki (2013). Ocular gene delivery systems using ternary complexes of plasmid DNA,
polyethylenimine, and anionic polymers. Biological and Pharmaceutical Bulletin 36: 96-101.
[201]
Leung KC, CP Chak, SF Lee, JM Lai, XM Zhu, YX Wang, KW Sham and CH Cheng (2013).
Enhanced cellular uptake and gene delivery of glioblastoma with deferoxamine-coated
nanoparticle/plasmid DNA/branched polyethylenimine composites. Chemical Communications
(Cambridge) 49: 549-551.
[202]
Levine RM, TR Pearce, M Adil and E Kokkoli (2013). Preparation and characterization of
liposome-encapsulated plasmid DNA for gene delivery. Langmuir 29: 9208-9215.
[203]
Henry CM (2001). Gene delivery without viruses. Chemical Engineering News 79: 35-41.
[204]
Herzog CD, L Brown, D Gammon, B Kruegel, R Lin, A Wilson, A Bolton, M Printz,
M Gasmi, KM Bishop,
et al
. (2009). Expression, bioactivity, and safety 1 year after adeno-
associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system
support cere-120 for Parkinson's disease. Neurosurgery 64: 602-612; discussion 612-613.
[205]
Zhang QF, WJ Yi, B Wang, J Zhang, L Ren, QM Chen, L Guo and XQ Yu (2013). Linear
polycations by ring-opening polymerization as non-viral gene delivery vectors. Biomaterials
34: 5391-5401.
[206]
Santos JL, E Oramas, AP Pego, PL Granja and H Tomas (2009). Osteogenic differentiation of
mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. Journal of
Controlled Release 134: 141-148.
